General Information
Revision date
2016-09-09
Product name
NAVELBINE 10 MG/ML AND 50 MG/5 ML FOR INFUSION
CAS No.
125317-39-7
Emergency telephone
INRS 33 (1) 45 42 59 59 (FRANCE
Icons in SDS
Company Information
company name
PIERRE FABRE MEDICAMENT
e-mail address of the competent person responsible for the Safety Data Sheet
FDS@pierre-fabre.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H341, H360D, H373
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
H360D
May damage the unborn child.
H373
May cause damage to organs through prolonged or repeated exposure
Section 2
CLP CLASSIFICATION
CLP]Mixture/Substance SDS EU 2015 According to Regulation (EU) 2015/830 (REACH Annex II) Germ cell mutagenicity, Category 2 H341 Reproductive toxicity, Category 1A H360D Specific target organ toxicity — Repeated exposure, Category 2 H373
Hazard statements
see section 16 : H341 - Suspected of causing genetic defects H360D - May damage the unborn child H373 - May cause damage to organs through prolonged or repeated exposure
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP] Extra labelling to displayExtra classification(s) to display
Hazard pictograms
GHS08
Signal word
Danger
Hazardous Ingredients
vinorelbine ditartrate
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P314 - Get medical advice/attention if you feel unwell P405 - Store locked up P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation
2.3 Other hazards
No additional information available